ROCHESTER, MINN. -- A daily dose of fish oil slows the progression of disease in people suffering from IgA nephropathy, a relatively common kidney disease with potentially serious consequences. An earlier Mayo Clinic-led study showed that, after two years, people who took the fish oil had significantly better kidney function and significantly fewer of them suffered advanced kidney failure than people who took a placebo.

A recent report in the Journal of the American Society of Nephrology shows that those benefits continue over time. Researchers followed all 106 of the original study participants for an average of more than six years. They found that the fish oil group fared better than the placebo group in two key areas: worsening of kidney function (the ability to process wastes) and kidney failure.

Placebo Fish oil
Worsening of kidney function 29 17
Severe kidney failure 19 8

Contact: Mike O'Hara
507-284-9522 (days)
507-284-2511 (evenings)
[email protected]

###

To receive Mayo news releases by e-mail, send a message to [email protected]. Include your name, affiliation, and e-mail address. Mayo Clinic news releases are available on the Mayo Home Page, http://www.mayo.edu. Mayo Clinic health information is available on Mayo Clinic Health Oasis at http://www.mayohealth.org.

MEDIA CONTACT
Register for reporter access to contact details